Section 3(i) Rejections Reversed: Diagnostic Methods Must Disclose Pathology Per Se

Featured image for article: Section 3(i) Rejections Reversed: Diagnostic Methods Must Disclose Pathology Per Se

In two recent decisions, the Madras High Court reversed patent application rejections under Section 3(i), clarifying that only diagnostic methods disclosing pathology per se fall within the exclusion. The Court remanded matters for fresh review, ensuring fair consideration and reasoned decisions by the IPO.

Read more about Section 3(i) Rejections Reversed: Diagnostic Methods Must Disclose Pathology Per Se

Clarifying Patentability of Plant Treatment Methods under Section 3(h) and 3(i)

Clarifying Patentability of Plant Treatment Methods under Section 3(h) and 3(i) Featured image for article: Clarifying Patentability of Plant Treatment Methods under Section 3(h) and 3(i)

The Delhi High Court, in Syngenta Crop Protection AG vs. Assistant Controller of Patents and Designs, examined the rejection of an Indian patent application under Section 3(h) of the Patents Act. The Court ruled that plant treatment methods are distinct from agricultural processes, referring to the 2003 amendment to Section 3(i), and remanded the case for fresh examination with amended claims.

Read more about Clarifying Patentability of Plant Treatment Methods under Section 3(h) and 3(i)

Methods for Antibody Production in Genetically Modified Animals are Patentable; they are not covered under Section 3(i) Exclusion

The Madras High Court has overturned the rejection of Kymab Limited’s patent application related to generating antibodies in non-human mammals. The Court found that the invention does not fall under Section 3(i) of the Patents Act, 1970, as it is not a method for treating animals but a process for producing antibodies using genetically modified animals. The patent is now set to be granted.

Read more about Methods for Antibody Production in Genetically Modified Animals are Patentable; they are not covered under Section 3(i) Exclusion

Method of producing ‘protein enriched blood serum’ is not a method of treatment under Section 3(i), says the Delhi High Court

Delhi High Court reviewed whether new objections can be raised at the hearing stage of a Patent Application. The Court examined the claims and the refusal order, from the purview of Principles of Natural Justice.

Read more about Method of producing ‘protein enriched blood serum’ is not a method of treatment under Section 3(i), says the Delhi High Court

Is a Method of Massaging Patentable subject matter?

The post analyses whether massage methods can be patented in India, highlighting the distinction between non-medical and medical methods under Section 3(i) of the Patents Act. It references UK practice and suggests the Indian Patent Office may follow similar standards in the absence of direct precedents.

Read more about Is a Method of Massaging Patentable subject matter?